Related Experiment Videos
Antimicrobial therapy of intra-abdominal sepsis
1Department of Surgery, University of Minnesota Hospital and Clinic, Minneapolis.
Abstract:
Intra-abdominal sepsis remains a highly morbid and lethal event despite the availability of potent antimicrobial agents and improvements in surgical management and intensive care. Appropriate management consists of source control, antimicrobial agents directed against both facultative gram-negative and anaerobic organisms, and physiologic and metabolic support. A variety of single and dual agent regimens are appropriate for initial therapy, as long as both aerobes and anaerobes are effectively targeted. Culture, Gram stain, and sensitivity testing may provide valuable information, especially when resistant organisms are encountered. Further studies to determine the relative efficacy of various agents need to be carefully designed both to avoid the pitfalls of previous studies and to provide useful and comparable data.
Insights
Intra-abdominal sepsis management requires source control and broad-spectrum antibiotics targeting aerobic and anaerobic bacteria. Careful patient monitoring and further studies are crucial for optimizing treatment strategies.
Area of Science:
- Infectious Diseases
- Surgical Critical Care
- Pharmacology
Background:
- Intra-abdominal sepsis presents significant morbidity and mortality despite advances in antimicrobial therapy, surgery, and critical care.
- Effective management hinges on source control, targeted antimicrobial agents, and comprehensive physiologic support.
- Current therapeutic approaches necessitate broad coverage against both facultative gram-negative and anaerobic pathogens.
Purpose of the Study:
- To review the current understanding of intra-abdominal sepsis management.
- To emphasize the importance of appropriate antimicrobial selection and source control.
- To highlight the need for well-designed future studies on antimicrobial efficacy.
Main Methods:
- Review of existing literature on intra-abdominal sepsis management.
- Analysis of recommended antimicrobial strategies for aerobic and anaerobic coverage.
- Discussion of diagnostic methods including Gram stain, culture, and sensitivity testing.
Main Results:
- Appropriate management involves source control, broad-spectrum antimicrobial agents, and supportive care.
- Both single and dual-agent regimens can be effective if they target aerobic and anaerobic organisms.
- Microbiological testing is valuable, particularly for identifying resistant organisms.
Conclusions:
- Optimal treatment for intra-abdominal sepsis requires a multifaceted approach including source control and effective antimicrobial therapy.
- Targeting both aerobic and anaerobic bacteria is essential for initial treatment regimens.
- Future research should focus on designing rigorous studies to compare the efficacy of different antimicrobial agents.